Real-time enrollment status for this cervical cancer clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 2:19 AM UTC
| NCT Number | NCT06079671 |
| Recruiting Status | Recruiting |
| Condition | Cervical Cancer |
| Phase | PHASE3 |
| Target Enrollment | 800 participants |
| Active Locations | 28 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | June 26, 2026 (3 weeks ago) |
As of July 19, 2026: Clinical trial NCT06079671 is currently recruiting participants. This phase3 study for cervical cancer is actively seeking new participants at 28 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06079671 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 28 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06079671 was last updated 3 weeks ago (June 26, 2026). HelloStudys verifies this status automatically.